SYNOPSIS This paper reports the experience of treating patients with hepatic cirrhosis and ascites with an aldosterone inhibitor in addition to conventional therapy. Good results are demonstrated in 13 patients previously resistant to treatment. Ratnoff and Patek (1942) commented that ascites was the most frequent and characteristic sign of hepatic cirrhosis, and the serious prognosis of this complication was evident from the six-month survival of only 50 % of their patients. Despite progress in therapy, the outlook remains extremely grave when the onset of ascites is insidious and when resistance develops to treatment with sodium restriction and standard diuretic agents (Sherlock, 1958) . Most authorities agree with Blakemore (1952) that intractable ascites represents an end stage of cirrhosis and that such patients have at best but a few months to live. Available measures include paracentesis abdominis, a temporary expedient which may lead to protein and electrolyte depletion, hypotension, and coma (Sherlock, 1958) , or various portal-systemic shunt operations (Blakemore, 1952; Linton, 1956; McDermott, 1960) . The last reduce portal pressure and obstruction to hepatic venous or lymphatic flow but affect only mechanical aspects of the disease. Operative mortality with resistant ascites may exceed 40% (Linton, 1956) , while the subsequent development of progressive hepatic failure or neuropsychiatric changes are also important considerations. Refractory ascites, therefore, is considered a strong contraindication to the surgical treatment of portal hypertension (Sherlock, 1958;  Blakemore, 1952; Mackby, 1960; Walker, 1957) , although newer techniques may justify some reappraisal (McDermott, 1960) .
Since patients with cirrhosis and ascites have features of excess aldosterone activity (Luetscher and Johnson, 1954) fluid retention has been directed toward methods of combating hyperaldosteronism. Bilateral adrenalectomy (Marson, 1954; Giuseffi, Werk, Larson, Shiff, and Elliott, 1957) has been effective only occasionally, presumably because of the dangers of the procedure in patients with liver disease and the difficulties involved in immediate and long-term postoperative management. Medical suppression of adrenocortical function has been attempted (Summerskill and Crabbe, 1957; Stormont, Crabbe, Fast, Wolfe, and Davidson, 1959) but the toxicity of the drugs available precludes their long-term use.
More recently, steroidal lactones (Kagawa, Cella, and van Arman, 1957) , which act as chemical antagonists of aldosterone (Liddle, 1958) , have been given by mouth without side-effects to patients with cirrhosis and have procured an initial diuresis, even when the ascites was refractory to standard measures (Clowdus, Higgins, Rosevear, and Summerskill, 1960; Henley, Streeten, and Pollard, 1960) .
The progress of patients with resistant ascites treated medically is rarely specified after they leave the hospital and depends on many factors associated with hepatic disease, but particularly on their ability to adhere to a strict regimen of diet and drugs. In this paper, details of an effective long-term medical regimen to control ascites previously resistant to medical management by using an aldosterone antagonist in combination with standard diuretics are described, and the progress of 13 patients thus treated for periods up to two years is reported. Special attention is given to relaxation of the dietary restriction of sodium, which is made possible with 286 William H. J. Summerskill, Bernard F. Clowdus, II, and John W. Rosevear MATERIALS AND METHODS a factor during the preceding two months in only one (Case 13). In the other patients, the cause of the cirrhosis Thirteen patients with cirrhosis (Table 1) were treated and its possible relationship to previous hepatitis was at first in a hospital and were examined subsequently uncertain (cryptogenic). Tense ascites had been present at intervals of two weeks to three months throughout for periods of one month to three years despite treatment the period of follow-up. The diagnosis of cirrhosis and was shown to be refractory for 10 days or longer was made on clinical grounds, being supported by to treatment with dietary restriction of sodium (less biochemical tests of liver function (Table I ) and, in than 10 mEq. in 24 hours), and combinations of meraleight instances, by histological examination of hepatic luride (mercuhydrin), chlorothiazide, or prednisone in tissue. Six patients (Cases 4, 5, 8, 9, 11, and 13) had been the hospital. Nine patients had required paracenteses chronic alcoholics, but continued alcoholism had been on two to 12 occasions during the preceding year, and During initial hospital treatment patients were given diets containing on analysis less than 10 mEq. of sodium and between 80 and 100 mEq. of potassium daily. Fluid intake was restricted only if azotaemia occurred. Weight was determined daily, and the volume, together with the sodium and potassium contents, of 278 specimens of 24-hour urine was determined during the treatment of patients 1 to 9. During the time in hospital and at follow-up appointments, chemical tests of liver function and concentrations of blood urea, together with serum sodium, potassium chloride, and bicarbonate, were measured at intervals by standard procedures. Determinations of ammonia in arterial blood using the method of Seligson and Hirahara (1957) , and electroencephalographic recordings, which were graded 0 to 4 (Summerskill, Clowdus, and Casey, 1960a) , were made on patients with neuropsychiatric changes. Exchangeable sodium, exchangeable potassium, and total body water were measured by using Na24, K42, and D20 as tracer substances, as described elsewhere (Summerskill et al., 1960a; Clowdus, 11, Summerskill, Casey, Higgins, and Orvis, 1961) .
PRELIMINARY ASSESSMENT AND RESPONSE TO INITIAL TREATMENT
Initially, all patients had evidence of severe hepatic disease with ascites and muscle wasting (Table I ).
Three patients were clinically jaundiced, one being deeply icteric. All had direct-reacting bilirubin in the serum. The concentration of serum albumin initially was 3 g. per 100 ml. or less in eight patients, and all who were not jaundiced had grossly abnormal retention of sulphobromophthalein (bromsulphalein). Serum glutamic oxalacetic transaminase activity and concentrations of globulin were abnormal in every instance. All patients were hypoprothrombinaemic, and the prothrombin time was unresponsive to treatment with vitamin K. Five patients (Cases 4, 7, 9, 10, and 13) had initial clinical and electroencephalographic evidence of impending hepatic coma, and two (Cases 1 and 10) had previously had coma following paracentesis. These considerations were felt to preclude any patient from consideration for surgical treatment.
After resistance of the ascites to a low-sodium diet with standard diuretic agents (mercuhydrin, chlorothiazide, and prednisone) had been confirmed, each patient was given medication with spirolactonealdactone, 400 to 1,200 mg. in two to four doses daily in combination with chlorothiazide, 500 to 1,000 mg. in two doses daily; meralluride (mercuhydrin), 2 ml. daily intramuscularly; or prednisone, 30 mg. daily in three doses (Fig. 1) (Table I  and Fig. 1 ), between 8 and 65 lb. in weight being lost in 12 to 42 days. The greatest loss of weight by an individual in 24 hours was 5j lb., this being associated with a 24-hour excretion of 337 mEq. or sodium. There was usually a delay of a week, and sometimes considerably longer, before the diuresis began. With aldactone alone, a moderately increased amount of sodium was excreted in association with trivial loss of weight. The addition of prednisone or aldactone doubled loss of weight and increased excretion of sodium more than fourfold, while the use of aldactone in combination with chlorothiazide or mercuhydrin promoted comparable loss in weight but greater excretion of sodium. Two drugs were more effective than one in combination with aldactone; greater loss of weight and excretion of sodium occurred when either mercuhydrin or chlorothiazide was added to aldactone and prednisone. The greatest loss of weight (water) in relation to urinary excretion of sodium and potassium occurred when prednisone was administered with aldactone; the addition of thiomerin or chlorothiazdie to this combination of drugs caused a proportionately greater increase in excretion of the cations than loss of weight. Loss of potassium was greatest during regimens in which chlorothiazide was incorporated, and least when aldactone was administered. When aldactone and chlorothiazide were given together, a negative potassium balance often occurred. (Table I ). The mean survival period in these cases was only four months, but gross ascites re-accumulated in only one (Case 6), this being due to occlusion of the portal vein by hepatoma.
Two patterns of response were defined during follow-up studies: (1) that of the patients who ultimately dispensed with diet and drugs, and (2) that of the patients who required continuous therapy. The second group of patients was subdivided into those who were able to continue strict sodium restriction at home (as shown by analysis of aliquots of their diets) and those in whom some relaxation of sodium intake was inevitable because of their inability to prepare or adhere to a correct diet. A trivial amount of ascites was allowed to accumulate in patients taking diuretics continuously as a precaution against sodium depletion.
PATIENTS RETURNING TO NORMAL DIETS WITHOUT
DIURETIC THERAPY Three patients (Cases 4, 1 1, and 13) were chronic alcoholics in whom ascites had developed within the year preceding treatment but who ceased drinking one to three months before entering the hospital. After initial treatment, liver function improved in patient 13 only. All avoided further consumption of alcohol, and a diet providing approximately 10 mEq. of sodium, a liberal intake of protein (through low-sodium supplements), and added vitamins was prescribed. Subsequently, none reaccumulated fluid, all gained flesh, and hepatomegaly decreased. Chemical tests of liver function improved commensurately (Table I ). (Clowdus et al., 1960) (Tables I  and II ). Before treatment, isotope studies on 11 patients confirmed the excess total body water (TBW) and exchangeable sodium (NaE) known to occur in patients with ascites (Birkenfeld, Liebman, O'Meara, and Edelman, 1958) . Paradoxical hyponatraemia (Talso, Spafford, Ferenzi, and Jackson, 1956) Long-term medical management and complications of 'resistant' ascites for total body water, NaE, and KE in patients subsequently having azotaemia reflected their smaller physiques as shown by the dry body weight. Otherwise the two groups could not be distinguished before treatment.
During diuresis, greater hyponatraemia developed, while three patients became azotaemic at this stage, and three more became azotaemic during subsequent management (Table II) . The presence of azotaemia was associated with symptoms, more striking metabolic changes, and a worse prognosis. The clinical syndrome consisted of apathy, nausea, and anorexia, progressing in more severe instances to personality changes and stupor. The motor system disorder of impending coma (flapping tremor, hyporeflexia, rigidity, and clonus) was not prominent. Mental changes were not specific, and abnormalities of the electroencephalogram, arterial pH, and arterial ammonia concentrations, if present, were not striking and did not become more severe as the condition deteriorated (Summerskill et al., 1960a) . Azotaemia developed in the absence of precipitating factors, such as gastrointestinal haemorrhage or paracentesis abdominis, and without evidence of pre-existing renal disease, alterations in systemic blood pressure, and volume of urine (which were recorded daily), or characteristic histological changes in the kidneys at necropsy. A smaller proportion of body water was lost by azotaemic patients than by the other patients. Losses of sodium were comparable, while relatively little potassium was lost by either group. There was much greater hyponatraemia in azotaemic patients in association with the greater water retention, but concentrations of serum potassium became raised without elevation of body potassium content (KE). These disorders were not related to changes in flesh, as little alteration occurred in dry body weight in either group (Table II) .
The patients who became azotaemic often had more severe liver disease on clinical assessment and more grossly deranged chemical tests of liver function (Table I) . Two (Cases 4 and 13) recovered simultaneously with improvement in liver function, whereas azotaemia, hyponatraemia, and hyperkalaemia persisted for periods of two to nine months before death in three other patients (Cases 9, 10, and 12). Sudden death of three azotaemic patients (Cases 2, 9, and 10) appeared to be primarily due to hyperkalaemia, as electrocardiograms showed characteristic abnormalities and no alternative explanation could be found at necropsy. There was no relationship between the type or amount of drugs prescribed and the onset of azotaemia; patients subsequently having this complication had received smaller quantities of drugs and had a slower diuretic response.
Treatment of overhydration and azotaemia was unsatisfactory. Hyponatraemia without raised concentrations of serum potassium or blood urea gave rise to no specific symptoms and corrected itself spontaneously after diuresis. In azotaemic patients, overhydration was controlled temporarily by restriction of fluids, but severe thirst made this difficult for longer-term use, and azotaemia progressed notwithstanding (Cases 2, 9, 10, and 12). The enhanced water diuresis with prednisone (30 to 45 mg. daily) was not sufficient to prevent the onset or progression of overhydration and azotaemia in five patients, nor did the administration of mannitol (5% solution) by vein cause weight loss in five patients already receiving diuretics. An increased urinary volume followed mannitol infusions but was accounted for by the fluid load administered. Four patients excreted an increased amount of sodium in the subsequent 48 hours (mean 20.5 mEq. of sodium per litre of mannitol administered).
HEPATIC COMA In addition to the neuropsychiatric changes during azotaemia, hepatic coma occurred as a terminal event following gastrointestinal haemorrhage in Cases 2, 6, and 8. Personality changes, non-specific tumour, and minor electroencephalographic abnormalities of grade 1 or 2 severity appeared to be due primarily to the severity of the liver disease on initial assessment in Cases 4, 9, 10, and 13. In Cases 1 (Fig. 2) and 7 transient impending coma was clearly related to treatment with chlorothiazide and responded quickly to withdrawal of the drug. In other cases, diuretic therapy, including chlorothiazide, had no direct influence on the neuropsychiatric changes, and three patients recovered during good diuretic responses.
Several problems associated with management during the development and course of disorders of water and electrolyte metabolism and azotaemia are illustrated by the progress in Case 10 (Fig. 3) . Prolonged treatment with sodium restriction and increasing doses of diuretics were necessary to initiate diuresis. After steady loss of weight, apathy, confusion, and anorexia appeared in association with more severe hyponatraemia and hyperkalaemia, neither of which could be explained from changes in body composition as there was no increase in hydration (as indicated by the ratios NaE + KE/ TBW) and no evidence of sodium depletion or potassium retention from the NaB and KB values.
The electrocardiogram showed gross changes of hyperkalaemia. Simultaneously, azotaemia developed, with deterioration in the electroencephalo- 
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ammonia, but without change in blood pressure or output of urine. The neuropsychiatric disorder was not influenced by withdrawal of protein and chlorothiazide, but restriction of potassium resulted in some improvement in serum potassium concentration and in the electrocardiographic pattern. Relative overhydration then occurred, with a fall in the ratio, NaE + KE/TBW. Despite restriction offluid, the concentration ofserum sodium continued to fall and azotaemia increased, although improvement in the NaE + KEBTBW ratio occurred subsequently.
With improvement in the general condition, an increased dietary intake of sodium was attempted in conjunction with higher doses of spirolactone and chlorothiazide, so as to relax dietary restrictions before discharge from the hospital. The weight remained stable when a 40-mEq. sodium diet was used, although the concentration of serum sodium continued to fall and that of the blood urea rose, whereas an 80-mEq. sodium diet resulted in accumulation of fluid. Improvement in serum sodium and blood urea concentrations occurred, and to facilitate discharge from the hospital, paracentesis was performed uneventfully. The further course was satisfactory only in relation to the fact that no further weight was gained. Precautions against excess intakes of water and potassium remained necessary, and serum potassium concentrations remained dangerously high, while hyponatraemia persisted and concentrations of blood urea fluctuated but never reverted to normal. On four occasions, mannitol was given without effect. Progressive anaemia occurred in association with the azotaemia; tests for occult blood in the stools had been negative on 12 occasions. There was no alteration of serum bilirubin concentration or other evidence of increased haemolysis, and blood smears, together with leucocyte and platelet counts, were unremarkable. The anaemia appeared to be associated with the impaired renal function, and blood transfusions were necessary. Longstanding constipation was aggravated by fluid restriction, and evacuation of faeces under caudal anaesthesia was necessary. Three days later the patient complained suddenly of progressive paralysis and died within five minutes, the mode of death being ascribed to hyperkalaemia, as there was no other explanation for it at post-mortem examination.
COMMENT
The long-term medical management of ascites has been emphasized less than immediate hospital treatment, although successful therapy depends particularly on perseverance with an unpalatable l 292 group.bmj.com on October 14, 2017 -Published by http://gut.bmj.com/ Downloaded from Long-term medical management and complications of 'resistant' ascites and technically difficult diet, while there is understandably little information available regarding the progress of patients when ascites is refractory to treatment. In our experience, the use of spirolactone in combination with other diuretics always overcame the initial resistance of ascites to other medical measures, although there was occasionally a delay of two weeks before diuresis began. Moreover, this treatment permitted the relaxation of dietary restriction of sodium (Clowdus et al., 1960) when necessary in subsequent management without fluid re-accumulating. The initial diuretic response was related to the number of drugs and the doses prescribed, but long-term management was achieved with less medication, the amount usually varying with the intake of sodium. Balance studies confirmed earlier observations regarding the metabolic effects of these various drugs. Spirolactone had a potassium conserving effect, whereas chlorothiazide increased the loss of potassium, and prednisone increased the excretion of water in relation to sodium and potassium (Clowdus et al., 1960; Cattan and Vesin, 1957; Dingman, Finkenstaedt, Laidlaw, Renold, Jenkins, Merrill, and Thorn, 1958; Shaldon, McLaren, and Sherlock, 1960; Laragh, Heinemann, and Demartini, 1958; Read, Laidlaw, Haslam, and Sherlock, 1959; Salassa, Mattox, and Power 1958) . Nevertheless, the simultaneous administration of aldactone and chlorothiazide often led to a negative potassium balance, while the increased diuresis of water associated with prednisone therapy did not necessarily prevent overhydration. The incidence of neuropsychiatric complications attributable to chlorothiazide in these and other patients treated by us was much below that reported by Read et al. (1959) , and potassium depletion was not proved to be the major factor. Concentrations of serum potassium are infrequently reliable indices of body stores of potassium in patients with ascites (Summerskill et al., 1960a; Clowdus, II, et al., 1961; Talso et al., 1956) , and the direct effect of chlorothiazide on ammonia metabolism (Owen, Flanagan, and Tyor, 1959; Mackie, Stormont, Hollister, and Davidson, 1958; Casey, Summerskill, and Orvis, 1961) seen in one of the patients reported herein was supported by the demonstration of an interrelationship between ammonia and potassium metabolism in others . This may explain the susceptibility of patients who had previously experienced coma to neuropsychiatric changes during chlorothiazide therapy and the raised arterial concentrations of ammonia under such circumstances, which is evident from earlier data (Read et al., 1959) . These considerations were of greatest importance during periods of rapid diuresis and when complications involving water and electrolyte metabolism occurred, but they seldom influenced long-term management because of the smaller doses of drugs necessary for maintenance. A combination of spirolactone and chlorothiazide was most convenient for long-term treatment but newer drugs may have fewer disadvantages.
The constant response to a drug acting primarily as an antagonist of aldosterone indicates the importance of hyperaldosteronism in the refractoriness of ascites to standard treatment. Such resistance appeared to be closely related to the severity of the liver disease, as patients in whom liver function ultimately improved dispensed with treatment, whereas others required continued diet and therapy with diuretics. A direct relationship between hyperaldosteronism and liver function (Summerskill and Crabbe, 1957; Coppage, Island, Cooner, and Liddle, 1961) or other factors important in the formation of ascites, however, remains speculative.
Resistant ascites associated with cirrhosis carried a more favourable long-term prognosis in the alcoholic than in the non-alcoholic, as greater recovery of liver function was possible as a result of a nutritious diet and abstinence from alcohol (Summerskill, Davidson, Dible, Mallory, Sherlock, Turner, and Wolfe, 1960b) . Nevertheless, relaxation of diuretic therapy and sodium restriction had to be gradual in the alcoholic. In contrast, patients with cirrhosis of uncertain cause pursued a more inexorable course (Summerskill et al., 1960b) (Chalmers, 1960) , and their relationship to deterioration in hepatic function appears to be most important, especially as two patients with severe hyponatraemia and azotaemia recovered when the liver disease improved.
Two uncertainly related phases were distinguished in this disorder, the first reflecting overhydration (Clowdus, II, et al., 1961; Birkenfeld et al., 1958; Talso et al., 1956 ) and the second comprising more severe overhydration in association with azotaemia and additional metabolic and clinical changes (Clowdus, II, etal., 1961) . Hyponatraemia represented primarily dilution due to a relatively greater excess of body water than sodium, rather than sodium depletion; hypokalaemia, when present, may reflect the same phenomenon as well as deficiency of potassium. However, potassium supplements infrequently lead to replenishment of potassium stores as judged by changes in body potassium , nor were they always effective in preventing coma during treatment with chlorothiazide. In addition to sodium retention, the relative excess of body water may result from diminished free water clearance (Schedl and Bartter, 1960) or excess ADH activity (Ralli, Robson, Clarke, and Hoagland, 1945) and it was particularly prominent when azotaemia developed. Although prednisone (Dingman et al., 1958) and mannitol (Shaldon et al., 1960; Schedl and Bartter, 1960) may enhance free water clearance in some patients, there was no significant clinical effect in our azotaemic group, perhaps beoause sodium diuresis was already in progress. Restriction of fluids limited overhydration most effectively but failed to halt azotaemia and caused great thirst.
Despite overhydration and consequent dilution, hyperkalaemia occurred with azotaemia and appeared important as a cause of death. It could not be related to retention of potassium, thus raising the possibility that redistribution of potassium from the intracellular to the extracellular compartments resulted in hyperkalaemia and contributed to hyponatraemia. Potassium restriction was not fully effective, and the use of insulin, glucose, and sorbitol in the treatment of hyperkalaemia must be considered also.
The impairment of renal function leading to azotaemia in our cases occurred without clinical or histological evidence of renal disease. A disorder of the renal circulation has been inferred by Papper, Belsky, and Bleifer (1959) and Hecker and Sherlock (1956) , although oliguria and hypotension were not invariably present in their patients. In our cases, azotaemia preceded detectable oliguria and peripheral vascular collapse, but renal plasma flow was low (Feichter, Summerskill, and Wakim, unpublished data) , as in three cases reported by Papper et al. (1959) . This appeared the most important cause of a diminished glomerular filtration rate, but the anatomical and pathological basis is conjectural. The occurrence of progressive anaemia in one azotaemic patient was of interest in view of the relationships between erythropoiesis and renal function. The poor immediate prognosis of severe hyponatraemia with azotaemia stressed by others (Papper et al., 1959; Hecker and Sherlock, 1956) was not altogether supported in our group, as these changes sometimes persisted for weeks or months and two patients recovered.
Secondary impairment of renal function may modify the clinical picture. The neuropsychiatric changes in azotaemic patients were not characteristic of hepatic coma and did not respond strikingly to restriction of protein and antibiotics. Abnormalities of the electroencephalogram, arterial pH, and blood ammonia concentration may be influenced by disorders of water and electrolyte metabolism and azotaemia (Chalmers, 1960; Webster and Gabuzda, 1959) , thus making separation of clinical patterns difficult in patients with severe liver disease.
Our patients had hepatic disease of a severity which precluded initial consideration of surgical treatment and militated against the successful medical or surgical management of any subsequent gastrointestinal haemorrhage. The therapeutic approach of choice to resistant ascites, therefore, must be evaluated in relation to improvements in conservative management, as well as in surgical techniques and results (McDermott, 1960; Welch, Welch, and Carter, 1959; Barker and Reemtsma, 1960) . The simultaneous improvement in liver function and portal hypertension (Reynolds, Geller, Kuzma, and Redeker, 1960) in cirrhosis of the alcoholic suggests that operation may be deferred for six months, so that response to medical treatment and the sincerity of abstention from alcohol can be assessed. Post-operative improvement in ascites may on occasion be related to abstinence from alcohol rather than to the operation itself, whereas hazardous operations are seldom warranted when continued alcoholism leads to hepatic failure. Until the various factors responsible for resistance of ascites in different patients are more clearly defined, surgical treatment would appear to be most clearly indicated for the relatively uncommon patient in whom resistant ascites is associated with apparently good liver function, the latter being judged particularly by general nutrition, the absence of jaundice or previous coma, and satisfactory blood coagulation. The demonstration of gastro-oesophageal varices would favour a portal-systemic shunt, particularly if gastrointestinal haemorrhage had occurred previously, whereas adrenalectomy might be considered
